His specialty areas include lung cancer, mesothelioma, and thymic tumors and the use of novel immunotherapies for the treatment of lung cancer. Dr. Velcheti’s clinical and translational research focuses on identifying patients with molecular changes in the tumor that can predict response to immunotherapy and expanding clinical trials focusing on immunotherapy and novel agents. Dr. Velcheti received his hematology/oncology fellowship training at the Yale-Comprehensive Cancer Center in New Haven, Connecticut.